J

Joinn Laboratories China Co Ltd
SSE:603127

Watchlist Manager
Joinn Laboratories China Co Ltd
SSE:603127
Watchlist
Price: 17.68 CNY -6.31% Market Closed
Market Cap: 11.1B CNY
Have any thoughts about
Joinn Laboratories China Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Joinn Laboratories China Co Ltd

Revenue
2.2B CNY
Cost of Revenue
-1.4B CNY
Gross Profit
812.4m CNY
Operating Expenses
-462.7m CNY
Operating Income
349.7m CNY
Other Expenses
-213.1m CNY
Net Income
136.6m CNY

Income Statement
Joinn Laboratories China Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
268
N/A
294
+10%
301
+2%
334
+11%
341
+2%
375
+10%
409
+9%
432
+6%
474
+10%
513
+8%
639
+25%
720
+13%
836
+16%
922
+10%
1 076
+17%
1 122
+4%
1 213
+8%
1 301
+7%
1 517
+17%
1 587
+5%
1 759
+11%
1 936
+10%
2 268
+17%
2 366
+4%
2 503
+6%
2 579
+3%
2 376
-8%
2 332
-2%
2 214
-5%
Gross Profit
Cost of Revenue
(134)
(137)
(132)
(148)
(157)
(175)
(192)
(207)
(228)
(250)
(310)
(355)
(412)
(461)
(525)
(549)
(596)
(645)
(779)
(820)
(920)
(998)
(1 184)
(1 238)
(1 356)
(1 440)
(1 395)
(1 412)
(1 401)
Gross Profit
134
N/A
157
+17%
170
+8%
186
+9%
185
-1%
200
+8%
216
+8%
225
+4%
247
+10%
263
+7%
329
+25%
365
+11%
424
+16%
461
+9%
551
+20%
573
+4%
617
+8%
656
+6%
738
+12%
766
+4%
839
+9%
938
+12%
1 084
+16%
1 129
+4%
1 147
+2%
1 139
-1%
982
-14%
920
-6%
812
-12%
Operating Income
Operating Expenses
(73)
(74)
(79)
(78)
(85)
(89)
(103)
(109)
(116)
(130)
(139)
(164)
(192)
(220)
(249)
(254)
(269)
(284)
(289)
(292)
(320)
(350)
(375)
(392)
(400)
(394)
(390)
(437)
(463)
Selling, General & Administrative
(76)
(78)
(57)
(85)
(92)
(92)
(82)
(95)
(96)
(104)
(108)
(138)
(159)
(182)
(209)
(243)
(262)
(278)
(253)
(270)
(297)
(316)
(289)
(324)
(316)
(311)
(298)
(313)
(323)
Research & Development
0
0
(26)
0
0
(8)
(23)
(21)
(29)
(32)
(38)
(44)
(52)
(62)
(47)
(49)
(44)
(37)
(43)
(50)
(51)
(63)
(73)
(93)
(109)
(106)
(88)
(92)
(88)
Depreciation & Amortization
0
0
(6)
0
0
0
(7)
0
0
0
(10)
0
0
0
(20)
0
0
0
(34)
0
0
0
(36)
0
0
0
(34)
0
0
Other Operating Expenses
3
5
9
8
7
10
9
6
10
7
17
18
18
24
27
38
37
32
41
29
29
29
22
26
26
22
30
(32)
(51)
Operating Income
61
N/A
83
+36%
91
+9%
108
+19%
100
-8%
111
+12%
114
+2%
116
+2%
131
+13%
134
+2%
190
+42%
201
+6%
232
+15%
241
+4%
303
+25%
319
+5%
348
+9%
373
+7%
449
+20%
474
+6%
519
+9%
588
+13%
708
+20%
737
+4%
748
+2%
745
0%
592
-21%
483
-18%
350
-28%
Pre-Tax Income
Interest Income Expense
1
1
3
6
9
12
12
15
16
16
26
21
20
16
58
127
103
136
194
201
371
492
518
564
174
155
204
(484)
(136)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
(0)
(0)
(0)
0
0
(0)
(289)
0
(1)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
Total Other Income
5
3
(1)
(1)
(1)
(1)
2
1
1
1
0
(1)
(1)
(1)
(0)
(4)
(1)
(1)
(1)
3
15
15
15
14
(0)
(0)
0
(0)
(0)
Pre-Tax Income
67
N/A
87
+31%
93
+7%
113
+21%
108
-4%
122
+13%
128
+5%
133
+4%
148
+12%
151
+2%
216
+42%
222
+3%
251
+13%
256
+2%
361
+41%
443
+23%
449
+2%
508
+13%
642
+26%
678
+6%
905
+33%
1 094
+21%
1 240
+13%
1 315
+6%
922
-30%
900
-2%
507
-44%
(1)
N/A
213
N/A
Net Income
Tax Provision
(10)
(13)
(17)
(21)
(21)
(23)
(20)
(21)
(22)
(24)
(29)
(28)
(30)
(29)
(47)
(55)
(58)
(64)
(86)
(90)
(131)
(154)
(167)
(179)
(129)
(131)
(115)
(69)
(83)
Income from Continuing Operations
57
74
76
92
87
99
108
111
126
128
187
194
222
227
314
388
391
443
556
588
774
940
1 073
1 136
792
768
392
(70)
130
Income to Minority Interest
0
0
0
0
0
0
0
0
0
1
0
0
0
1
1
1
2
1
1
1
1
1
1
1
1
1
5
7
7
Net Income (Common)
57
N/A
74
+30%
76
+3%
92
+21%
87
-6%
99
+14%
108
+9%
112
+3%
126
+13%
128
+2%
187
+46%
194
+4%
222
+14%
228
+3%
315
+38%
389
+24%
393
+1%
445
+13%
557
+25%
589
+6%
775
+31%
941
+22%
1 074
+14%
1 137
+6%
794
-30%
770
-3%
397
-48%
(63)
N/A
137
N/A
EPS (Diluted)
0.34
N/A
0.44
+29%
0.41
-7%
0.41
N/A
0.38
-7%
0.44
+16%
0.48
+9%
0.49
+2%
0.56
+14%
0.57
+2%
0.82
+44%
0.85
+4%
1.01
+19%
1.01
N/A
1.39
+38%
1.58
+14%
0.72
-54%
0.75
+4%
0.77
+3%
1.1
+43%
1.43
+30%
1.22
-15%
1.43
+17%
1.51
+6%
1.06
-30%
1.03
-3%
0.53
-49%
-0.09
N/A
0.18
N/A

See Also

Discover More